Latest Stakk (ASX:SKK) News

AI infrastructure names drove the biggest moves this week, with DXN exploding higher and Stakk extending its run after a new US healthcare contract. Elsewhere, capital raisings, takeover moves and executive changes kept tech investors busy, while several early gap-ups faded as buying cooled.

Stakk Ltd has secured a significant U.S. healthcare technology contract, pushing its annualised revenue run rate to approximately A$26 million. The deal highlights accelerating adoption of its AI-native Digital Trust platform across regulated industries.

Robotics, AI chips and defence software drove the week’s biggest technology moves, but not every early jump held. Investors chased clear revenue growth and contract wins, while cash pressure and equity raisings kept a lid on parts of the sector.

Stakk Ltd has reported a striking 186% quarter-on-quarter revenue jump to A$5.52 million in Q1 2026, driven by converting contracted clients into active billing and new engagements, underpinning strong recurring revenue and cash flow.

Speculative resources names drove the biggest moves this week, with Patriot Resources, Brazilian Critical Minerals and Rent.com.au leading the gainers. At the other end, Qoria, SQX Resources and 4DMedical fell hard as capital raisings, weak follow-through and post-gap selling hit sentiment.

Speculative tech names drove the biggest swings this week, while data centres and software groups kept tapping investors for growth capital. The clearest pattern was simple: companies that showed revenue, contracts or cash support were rewarded, but some early price jumps faded fast when buyers stepped back.

Stakk Ltd (ASX: SKK) has delivered a striking 272% jump in gross receipts to $5.36 million in Q3 FY26, reversing prior cash outflows with a positive net cash flow of $2.25 million and closing the quarter with $17.34 million in cash.

A small-cap tech week where one US gaming platform build lit the fuse, while a big semiconductor raise kept sliding after the halt. Deals and contracts did the heavy lifting, but several “open higher, finish lower” sessions showed buyers are still picky.

Stakk Limited’s U.S. subsidiary has landed its largest-ever contract worth A$7.85 million, marking a significant step in expanding its AI-native trust infrastructure across regulated industries including healthcare.

One stock nearly doubled, another jumped more than 40%, and a finance heavyweight stayed elevated after a merger shock. In resources, the winners were mostly tied to “what was bought” or “what was funded”, while the laggards were often the ones where early optimism quickly turned into selling.

A single trading halt lit a fire under one small-cap, while a string of fundraisings reminded investors how often growth still needs fresh cash. Elsewhere, “AI-first” is splitting into two camps: products that ship now, and stories that still need proof.

Stakk Limited defies the tech sector slowdown by securing nine new institutional clients in February, adding $1.67 million in annualised recurring revenue and reinforcing its AI-driven platform’s market traction.